Skip to main content
SpringerLink
Log in

Proton Therapy for Thoracoabdominal Tumors

  • Chapter
  • First Online:
Ion Beam Therapy

Part of the book series: Biological and Medical Physics, Biomedical Engineering ((BIOMEDICAL,volume 320))

  • 1995 Accesses

Abstract

In advanced-stage disease of certain thoracoabdominal tumors, proton therapy (PT) with concurrent chemotherapy may be an option to reduce side effects. Several technological developments, including a respiratory gating system and implantation of fiducial markers for image guided radiation therapy (IGRT), are necessary for the treatment in thoracoabdominal tumors. In this chapter, the role of PT for tumors of the lung, the esophagus, and liver are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. A. Jemal, R. Siegel, E. Ward, et al., Cancer statistics, CA Cancer J. Clin. 56, 106–130 (2006)

    Article  Google Scholar 

  2. H. Asamura, T. Goya, Y. Koshiishi, et al., A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J. Thorac. Oncol. 3, 46–52 (2008)

    Article  Google Scholar 

  3. M.T. van Rens, A.B. de la Riviere, H.R. Elbers, et al., Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 117, 374–379 (2000)

    Article  Google Scholar 

  4. C.H. Lee, D. Tait, A.E. Nahum, et al., Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). Br. J. Radiol. 72, 1078–1084 (1999)

    Google Scholar 

  5. C. Wang, H. Nakayama, S. Sugahara, et al., Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer. Strahlenther Onkol. 185, 231–234 (2009)

    Article  Google Scholar 

  6. J.Y. Chang, X. Zhang, X. Wang, et al., Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 65, 1087–1096 (2006)

    Article  Google Scholar 

  7. D.E. Dosoretz, M.J. Katin, P.H. Blitzer, et al., Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int. J. Radiat. Oncol. Biol. Phys. 24, 3–9 (1992)

    Article  Google Scholar 

  8. G.S. Sibley, T.A. Jamieson, L.B. Marks, et al., Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int. J. Radiat. Oncol. Biol. Phys. 40, 149–154 (1998)

    Article  Google Scholar 

  9. H. Blomgren, I. Lax, I. Naslund, et al., Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 34, 861–870 (1995)

    Google Scholar 

  10. R.C. McGarry, L. Papiez, M. Williams, et al., Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int. J. Radiat. Oncol. Biol. Phys. 63, 1010–1015 (2005)

    Article  Google Scholar 

  11. Y. Nagata, K. Takayama, Y. Matsuo, et al., Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int. J. Radiat. Oncol. Biol. Phys. 63, 1427–1431 (2005)

    Article  Google Scholar 

  12. J. Wulf, U. Haedinger, U. Oppitz, et al., Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int. J. Radiat. Oncol. Biol. Phys. 60, 186–196 (2004)

    Article  Google Scholar 

  13. D.A. Bush, J.D. Slater, R. Bonnet, et al., Proton-beam radiotherapy for early-stage lung cancer. Chest 116, 1313–1319 (1999)

    Article  Google Scholar 

  14. D.A. Bush, J.D. Slater, B.B. Shin, et al., Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 126, 1198–1203 (2004)

    Article  Google Scholar 

  15. Y. Shioyama, K. Tokuuye, T. Okumura, et al., Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 56, 7–13 (2003)

    Article  Google Scholar 

  16. K. Nihei, T. Ogino, S. Ishikura, et al., High-dose proton beam therapy for Stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 65, 107–111 (2006)

    Article  Google Scholar 

  17. H. Nakayama, S. Sugahara, M. Tokita, et al., Proton beam therapy for patients with medically inoperable Stage I non-small-cell lung cancer at the University of Tsukuba. Int. J. Radiat. Oncol. Biol. Phys. 78, 467–471 (2010)

    Article  Google Scholar 

  18. M. Hata, K. Tokuuye, K. Kagei, et al., Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int. J. Radiat. Oncol. Biol. Phys. 68, 786–793 (2007)

    Article  Google Scholar 

  19. K. Furuse, M. Fukuoka, M. Kawahara, et al., Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J. Clin. Oncol. 17, 2692–2699 (1999)

    Google Scholar 

  20. P. Fournel, G. Robinet, P. Thomas, et al., Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d’Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95–01 Study. J. Clin. Oncol. 23, 5910–5917 (2005)

    Article  Google Scholar 

  21. J.G. Rosenman, J.S. Halle, M.A. Socinski, et al., High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. Int. J. Radiat. Oncol. Biol. Phys. 54, 348–356 (2002)

    Article  Google Scholar 

  22. S.E. Schild, W.L. McGinnis, D. Graham, et al., Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 65, 1106–1111 (2006)

    Article  Google Scholar 

  23. M.A. Socinski, A.W. Blackstock, J.A. Bogart, et al., Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J. Clin. Oncol. 26, 2457–2463 (2008)

    Article  Google Scholar 

  24. B.H. Burmeister, B.M. Smithers, V. Gebski, et al., Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet 6, 659–668 (2005)

    Article  Google Scholar 

  25. J.S. Cooper, M.D. Guo, A. Herskovic, et al., Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group. J. Am. Med. Assoc. 281, 1623–1627 (1999)

    Google Scholar 

  26. V. Gebski, B. Burmeister, B.M. Smithers, et al., Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet 8, 226–234 (2007)

    Article  Google Scholar 

  27. S. Sugahara, K. Tokuuye, T. Okumura, et al., Clinical results of proton beam therapy for cancer of the esophagus. Int. J. Radiat. Oncol. Biol. Phys. 61, 76–84 (2005)

    Article  Google Scholar 

  28. N. Fukumitsu, K. Tokuuye, S. Sugahara, et al., A patient surviving for eight years after proton and X-ray irradiation for advanced esophageal cancer. Acta Oncol. 45, 1132–1134 (2006)

    Article  Google Scholar 

  29. M. Mizumoto, S. Sugahara, H. Nakayama, et al., Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther Onkol. 186, 482–488 (2010)

    Article  Google Scholar 

  30. T. Iizuka, K. Isono, T. Kakegawa, H. Watanabe, Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese committee for registration of esophageal carcinoma cases. Chest 96, 1005–1011 (1989)

    Google Scholar 

  31. H. Akiyama, M. Tsurumaru, H. Udagawa, et al., Radical lymph node dissection for cancer of the thoracic esophagus. Ann. Surg. 220, 364–373 (1994)

    Article  Google Scholar 

  32. B.D. Minsky, T.F. Pajak, R.J. Ginsberg, et al., INT 0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J. Clin. Oncol. 20, 1167–1174 (2002)

    Article  Google Scholar 

  33. X. Zhang, K.L. Zhao, T.M. Guerrero, et al., Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. Int. J. Radiat. Oncol. Biol. Phys. 72, 278–287 (2008)

    Article  Google Scholar 

  34. D.M. Parkin, F. Bray, J. Felay, et al., Estimating the world cancer burden: GLOBOCAN 2000. Int. J. Cancer 94, 153–156 (2001)

    Article  Google Scholar 

  35. H.B. El-Serag, K.L. Rudolph, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557–2576 (2007)

    Article  Google Scholar 

  36. S.F. Altekruse, K.A. McGlynn, M.E. Reichman, Hepatocellular carcinoma incidence, mortality and survival trends in the United States from 1975 to 2005. J. Clin. Oncol. 27, 1485–1491 (2009)

    Article  Google Scholar 

  37. F.X. Bosch, J. Ribes, M. Diaz, R. Cleries, Primary liver cancer: worldwide incidence and trends. Gastroenterology 124, S5–S16 (2004)

    Article  Google Scholar 

  38. H.B. El-Serag, K.L. Rudolph, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557–2576 (2007)

    Article  Google Scholar 

  39. R. Ian, M.D. Wanless, Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 22, 983–993 (1995)

    Google Scholar 

  40. M. Sakamoto, S. Hirohashi, H. Tsuda, et al., Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am. J. Surg. Pathol. 13, 1064–1067 (1989)

    Article  Google Scholar 

  41. O. Matsui, M. Kadoya, T. Kameyama, et al., Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 173,123–126 (1989)

    Google Scholar 

  42. J. Yamamoto, S. Iwatsuki, T. Kosuge, et al., Should hepatomas be treated with hepatic resection or transplantation? Cancer 86, 1151–1158 (1999)

    Article  Google Scholar 

  43. S.A. Curley, F. Izzo, L.M. Ellis, et al., Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann. Surg. 232, 381–391 (2000)

    Article  Google Scholar 

  44. S.M. Lin, C.J. Lin, C.C. Lin, et al., Randomized controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54, 1151–1156 (2005)

    Article  Google Scholar 

  45. J.M. Llovet, J. Bruix, Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37, 429–442 (2003)

    Article  Google Scholar 

  46. J. Ingold, G. Reed, H. Kaplan, Radiation hepatitis. Am. J. Roentgenol. Radium Ther. Nucl. Med. 93, 200–208 (1965)

    Google Scholar 

  47. B. Emami, J. Lyman, A. Brown, et al., Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21, 109–122 (1991)

    Google Scholar 

  48. Y. Matsuzaki, T. Osuga, Y. Saito, et al., A new, effective and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology 106, 1032–1041 (1994)

    Google Scholar 

  49. S. Komatsu, Y. Hori, T. Fukumoto, et al., Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma. World J. Gastroenterol. 16, 1800–1803 (2010)

    Article  Google Scholar 

  50. K. Ohara, T. Okumura, M. Akisada, et al., Irradiation synchronized with respiration gate. Int. J. Radiat. Oncol. Biol. Phys. 17, 853–857 (1989)

    Article  Google Scholar 

  51. H. Shirato, S. Shimizu, K. Kitamura, et al., Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. Int. J. Radiat. Oncol. Biol. Phys. 48, 435–442 (2000)

    Article  Google Scholar 

  52. H. Onishi, K. Kuriyama, T. Komiyama, et al., Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 45, 45–55 (2004)

    Article  Google Scholar 

  53. D. Verellen, M. De Ridder, G. Storme, A (short) history of image-guided radiotherapy. Radiother. Oncol. 86, 4–13 (2008)

    Article  Google Scholar 

  54. H. Nakayama, S. Sugahara, M. Tokita, et al., Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer 115, 5499–5506 (2009)

    Article  Google Scholar 

  55. M. Kawashima, J. Furuse, T. Nishio, et al., Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J. Clin. Oncol. 23, 1839–1846 (2005)

    Article  Google Scholar 

  56. D.A. Bush, D.J. Hillebrand, J.M. Slater, et al., High-dose proton radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 127, S189–S193 (2004)

    Article  Google Scholar 

  57. N. Fukumitsu, S. Sugahara, H. Nakayama, et al., A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 74, 831–836 (2009)

    Article  Google Scholar 

  58. M. Mizumoto, K. Tokuuye, S. Sugahara, et al., Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int. J. Radiat. Oncol. Biol. Phys. 71, 462–467 (2008)

    Article  Google Scholar 

  59. H. Tsuji, T. Okumura, A. Maruhashi, et al., Dose-volume histogram analysis of patients with hepatocellular carcinoma regarding changes in liver function after proton therapy. Nippon Igaku Hoshasen Gakkai Zasshi. 55, 322–328 (1995)

    Google Scholar 

  60. K. Ohara, T. Okumura, H. Tsuji, et al., Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 38, 367–372 (1997)

    Article  Google Scholar 

  61. H. Tsujii, H. Tsuji, T. Inada, et al., Clinical results of fractionated proton therapy. Int. J. Radiat. Oncol. Biol. Phys. 25, 49–60 (1992)

    Google Scholar 

  62. T. Chiba, K. Tokuuye, Y. Matsuzaki, et al., Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin. Cancer Res. 11, 3799–3805 (2005)

    Article  Google Scholar 

  63. K. Ohara, T. Okumura, H. Tsuji, et al., Clearance of parenchymal tumors following radiotherapy: analysis of hepatocellular carcinomas treated by proton beams. Radiother. Oncol. 41, 233–236 (1996)

    Article  Google Scholar 

  64. T. Ahmadi, Y. Itai, H. Onaya, et al., CT evaluation of hepatic injury following proton beam irradiation: Appearance, enhancement, and 3D size reduction pattern. J. Comp. Assist. Tomogr. 23, 655–663 (1999)

    Article  Google Scholar 

  65. S. Sugahara, Y. Oshiro, H. Nakayama, et al., Proton beam therapy for large hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 76, 460–466 (2009)

    Article  Google Scholar 

  66. S. Sugahara, H. Nakayama, K. Fukuda, et al., Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol. 85, 782–788 (2009)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Proton Medical Research Center, Department of Radiation Oncology, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki, 305-8575, Japan

    Hideyuki Sakurai & Toshiyuki Okumura

  2. Department of Radiology, Tokyo Medical University, Ibaraki Medical Center, Amimachi-chuo 3-20-1, Inashiki, Ibaraki, 300-0395, Japan

    Shinji Sugahara

  3. Department of Radiology, Tokyo Medical University, Shinjuku 6-1-1, Shinjuku-ku, Tokyo, 160-0022, Japan

    Hidetsugu Nakayama & Koichi Tokuuye

Authors
  1. Hideyuki Sakurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiyuki Okumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shinji Sugahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hidetsugu Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Koichi Tokuuye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideyuki Sakurai .

Editor information

Editors and Affiliations

  1. Forschungszentrum Jülich, Jülich, 52425, Germany

    Ute Linz

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sakurai, H., Okumura, T., Sugahara, S., Nakayama, H., Tokuuye, K. (2012). Proton Therapy for Thoracoabdominal Tumors. In: Linz, U. (eds) Ion Beam Therapy. Biological and Medical Physics, Biomedical Engineering, vol 320. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21414-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-21414-1_13

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-21413-4

  • Online ISBN: 978-3-642-21414-1

  • eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)

Publish with us

Policies and ethics

Search

Navigation